Showing results (171-180 of 931) with videos related to
Sort By:
Pageof 94
American Journal of Hematology|July 15, 2016
Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphomaRose Lou Marie C Agbay, Nitin Jain, Sanam Loghavi, et al.Frontiers in Oncology|March 11, 2022
Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic LeukemiaXue Yi, Nitin Jain, LaKesla R Iles, et al.Circulation|September 10, 2009
A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging StudyMarc G Weisskopf, Nitin Jain, Huiling Nie, et al.Journal of Immunotherapy and Precision Oncology|November 11, 2024
Unexpected Mediastinal Mass Etiology in B-Acute Lymphoblastic LeukemiaLuan Phan, Elias Jabbour, Mara B Antonoff, et al.Molecules (Basel, Switzerland)|September 28, 2021
Controlling the Substrate Specificity of an Enzyme through Structural Flexibility by Varying the Salt-Bridge DensityJuan Huang, Qin Xu, Zhuo Liu, et al.The Lancet. Haematology|January 17, 2017
Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trialPreetesh Jain, Michael Keating, Sarah Renner, et al.British Journal of Haematology|November 23, 2017
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximabPreetesh Jain, Graciela M Nogueras González, Rashmi Kanagal-Shamanna, et al.Cancer|March 9, 2010
Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapiesElias Jabbour, Deborah Thomas, Jorge Cortes, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|July 21, 2004
Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapyRandall S Scheibel, Alan D Valentine, Susan O'Brien, et al.Annals of Internal Medicine|December 21, 2006
New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistanceHagop M Kantarjian, Moshe Talpaz, Francis Giles, et al.Pageof 94